AMNEAL PHARMACEUTICALS INC (AMRX) Stock Institutional Trading Activity


AMNEAL PHARMACEUTICALS INC (AMRX) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC and Viking Global Investors. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Renaissance Technologies LLCSell-73,50016,400$206,640
Q3 2025Renaissance Technologies LLCSell-338,10089,900$899,899
Q2 2025Renaissance Technologies LLCSell-196,700428,000$3,462,520
Q1 2025Renaissance Technologies LLCSell-61,800624,700$5,234,986
Q4 2024Renaissance Technologies LLCSell-69,100686,500$5,437,080
Q3 2024Renaissance Technologies LLCBuy72,900755,600$6,286,592
Q2 2024Renaissance Technologies LLCBuy149,970682,700$4,335,145
Q1 2024Renaissance Technologies LLCBuy324,930532,730$3,228
Q4 2023Renaissance Technologies LLCBuy93,700207,800$1,261
Q3 2023Renaissance Technologies LLCBuy37,700114,100$482
Q4 2022Renaissance Technologies LLCSell-65,50076,400$152
Q3 2022Renaissance Technologies LLCSell-30,500141,900$287
Q2 2022Renaissance Technologies LLCBuy103,800172,400$548
Q1 2022Renaissance Technologies LLCSell-380,06068,600$286
Q1 2021Renaissance Technologies LLCBuy276,111448,660$3,019
Q4 2020Renaissance Technologies LLCBuy100,849172,549$789
Q2 2019Renaissance Technologies LLCSell-315,70071,700$514
Q1 2019Renaissance Technologies LLCSell-566,300387,400$5,489
Q4 2018Renaissance Technologies LLCBuy573,000953,700$12,904
Q4 2018Viking Global InvestorsBuy815,6292,353,204$31,839
Q3 2018Renaissance Technologies LLCBuy380,700380,700$8,448
Q3 2018Viking Global InvestorsBuy1,537,5751,537,575$34,119

Frequently asked questions about AMRX activity

  • Which institutional owners are buying AMRX?

    Institutional owners buying AMRX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in AMRX activity?

    "Buy" means an investor increased their reported position in AMRX compared to the prior reporting period. This reflects growing exposure to AMNEAL PHARMACEUTICALS INC (AMRX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in AMRX increasing?

    Institutional interest in AMRX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.